China Resources Sanjiu Medical & Pharmaceutical Co Ltd

China Resources Sanjiu released its 2026 interim report, with net profit attributable to the parent company of 1.671 billion yuan, a decrease of 7.96% compared with the same period last year. The company's total operating revenue was 15.014 billion yuan, up 1.37% year-on-year, achieving growth for five consecutive years. Net cash inflow from operating activities was 2.423 billion yuan, down 15.29% year-on-year. The company's latest asset-liability ratio was 29.92%, gross margin was 56.79%, ROE was 7.32%, and diluted earnings per share was 1.00 yuan.

The National Medical Products Administration issued Announcement No. 66, mandating a unified revision of the package insert for oral Ganmaoling preparations, explicitly stating that patients must not drive motor vehicles, vessels, or engage in high-altitude operations while taking the medicine. This revision extends the no-driving warning, previously only required for compound Ganmaoling preparations, to all oral Ganmaoling dosage forms, including granules, capsules, tablets, and teas. Relevant companies must complete the filing of the new package inserts by October 15, 2026, and replace the inserts and labels of already-shipped products within nine months after filing. China Resources Sanjiu, whose core product is 999 Ganmaoling, faces a test. Its 999 Ganmaoling Granules surpassed 2 billion yuan in sales in China's retail pharmacy terminal respiratory system Chinese patent medicine market in 2025, ranking first in the Chinese patent medicine cold and cough category for twelve consecutive years. China Resources Sanjiu's self-care business revenue in 2025 was approximately 15.111 billion yuan, down 14.67 percent year-on-year, and its attributable net profit in the first half of 2026 was about 1.672 billion yuan, down 7.9 percent year-on-year. Experts believe the new regulation will lead to structural sales diversion, and costs such as packaging material replacement cannot be underestimated.

China Resources Sanjiu released its 2026 first-half earnings flash, with net profit attributable to the parent of approximately 1.67 billion yuan, a year-on-year decline of 7.90%. The company achieved total operating revenue of about 15.01 billion yuan, up 1.37% year-on-year. Recurring net profit attributable to the parent was approximately 1.6 billion yuan, down 5.87% year-on-year. At the end of the reporting period, total assets stood at about 55.857 billion yuan, equity attributable to the parent was about 22.874 billion yuan, and net assets per share attributable to the parent were 13.74 yuan. The company stated it continues to promote a dual-wheel drive of innovation and brand, strengthening R&D innovation and intelligent digital empowerment. In the first quarter, the company achieved revenue of 8.13 billion yuan and net profit attributable to the parent of 1.076 billion yuan.